Holders — by stockHoldings — by fund
Parkman Healthcare Partners LLC
Everything this manager disclosed owning in US-listed stocks — its complete Form 13F portfolio · as of 2026-06-30 · filed with the SEC up to 45 days after quarter end · CIK 0001777015
$976.8M
disclosed book value
77
positions
4.5%
largest position share
Positions, as of 2026-06-30
top 77 of 77 · 13F covers long US-listed positions only — cash, bonds, private and foreign stakes are not disclosed · PUT/CALL tags = options positions (share-equivalents), not shares held
| # | Issuer | Shares | Value | % of book |
|---|---|---|---|---|
| 1 | MBXMBX BIOSCIENCES INC | 800,173 | $44.2M | 4.5% |
| 2 | LLYELI LILLY & CO | 35,000 | $42.0M | 4.3% |
| 3 | CVSCVS HEALTH CORP | 391,791 | $40.5M | 4.1% |
| 4 | DXCMDEXCOM INC | 534,767 | $36.0M | 3.7% |
| 5 | PTCTPTC THERAPEUTICS INC | 435,691 | $35.5M | 3.6% |
| 6 | RCUSARCUS BIOSCIENCES INC | 919,266 | $28.3M | 2.9% |
| 7 | GPCRSTRUCTURE THERAPEUTICS INC | 485,661 | $26.1M | 2.7% |
| 8 | VRDNVIRIDIAN THERAPEUTICS INC | 1.4M | $25.3M | 2.6% |
| 9 | AGIOAGIOS PHARMACEUTICALS INC | 669,046 | $24.8M | 2.5% |
| 10 | INBXINHIBRX BIOSCIENCES INC | 256,950 | $24.3M | 2.5% |
| 11 | XENEXENON PHARMACEUTICALS INC | 397,379 | $24.0M | 2.5% |
| 12 | EWTXEDGEWISE THERAPEUTICS INC | 577,036 | $23.4M | 2.4% |
| 13 | UNHUNITEDHEALTH GROUP INC | 55,921 | $23.2M | 2.4% |
| 14 | SYKSTRYKER CORPORATION | 67,973 | $21.4M | 2.2% |
| 15 | IQVIQVIA HLDGS INC | 105,811 | $20.4M | 2.1% |
| 16 | ZBHZIMMER BIOMET HOLDINGS INC | 232,557 | $20.0M | 2% |
| 17 | PODDINSULET CORP | 131,378 | $20.0M | 2% |
| 18 | ASMBASSEMBLY BIOSCIENCES INC | 721,181 | $19.8M | 2% |
| 19 | SNDXSYNDAX PHARMACEUTICALS INC | 877,256 | $19.2M | 2% |
| 20 | EYPTEYEPOINT INC | 1.3M | $18.4M | 1.9% |
| 21 | THCTENET HEALTHCARE CORP | 97,280 | $18.2M | 1.9% |
| 22 | LIVANOVA PLC | 210,529 | $17.3M | 1.8% |
| 23 | ANIPANI PHARMACEUTICALS INC | 202,907 | $16.8M | 1.7% |
| 24 | BCRXBIOCRYST PHARMACEUTICALS INC | 1.6M | $16.2M | 1.7% |
| 25 | ALNYALNYLAM PHARMACEUTICALS INC | 50,672 | $15.3M | 1.6% |
| 26 | INDVINDIVIOR PHARMACEUTICALS INC | 364,269 | $14.9M | 1.5% |
| 27 | NVSTENVISTA HOLDINGS CORPORATION | 553,916 | $14.6M | 1.5% |
| 28 | DRUGBRIGHT MINDS BIOSCIENCES INC | 205,053 | $14.4M | 1.5% |
| 29 | XERSXERIS BIOPHARMA HOLDINGS INC | 1.8M | $14.3M | 1.5% |
| 30 | AVTXAVALO THERAPEUTICS INC | 766,290 | $14.2M | 1.4% |
| 31 | FDMT4D MOLECULAR THERAPEUTICS IN | 948,184 | $12.6M | 1.3% |
| 32 | IMNMIMMUNOME INC | 594,202 | $12.6M | 1.3% |
| 33 | STOKSTOKE THERAPEUTICS INC | 355,443 | $11.6M | 1.2% |
| 34 | WATWATERS CORP | 30,206 | $11.3M | 1.2% |
| 35 | ANROALTO NEUROSCIENCE INC | 429,035 | $11.3M | 1.2% |
| 36 | ORKAORUKA THERAPEUTICS INC | 113,188 | $10.8M | 1.1% |
| 37 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 486,984 | $10.4M | 1.1% |
| 38 | ABSIABSCI CORPORATION | 894,374 | $10.4M | 1.1% |
| 39 | MLYSMINERALYS THERAPEUTICS INC | 380,354 | $10.3M | 1.1% |
| 40 | COGTCOGENT BIOSCIENCES INC | 253,365 | $9.8M | 1% |
| 41 | UNIQURE NV | 208,170 | $9.6M | 1% |
| 42 | TARSTARSUS PHARMACEUTICALS INC | 150,000 | $9.4M | 1% |
| 43 | AMRXAMNEAL PHARMACEUTICALS INC | 541,190 | $9.4M | 1% |
| 44 | IRTCIRHYTHM HOLDINGS INC | 67,267 | $8.0M | 0.8% |
| 45 | CYRXCRYOPORT INC | 508,324 | $8.0M | 0.8% |
| 46 | BSXBOSTON SCIENTIFIC CORP | 180,481 | $7.7M | 0.8% |
| 47 | CLYMCLIMB BIO INC | 563,484 | $7.3M | 0.8% |
| 48 | AMLXAMYLYX PHARMACEUTICALS INC | 398,782 | $7.2M | 0.7% |
| 49 | UPBUPSTREAM BIO INC | 935,247 | $6.5M | 0.7% |
| 50 | RMDRESMED INC | 32,983 | $6.4M | 0.7% |
| 51 | UROGEN PHARMA LTD | 174,064 | $6.4M | 0.7% |
| 52 | ALGNALIGN TECHNOLOGY INC | 36,963 | $6.2M | 0.6% |
| 53 | CARLCARLSMED INC | 597,318 | $6.2M | 0.6% |
| 54 | AVAHAVEANNA HEALTHCARE HLDGS INC | 714,451 | $6.1M | 0.6% |
| 55 | CDNACAREDX INC | 202,417 | $5.8M | 0.6% |
| 56 | SIBNSI BONE INC | 328,686 | $5.4M | 0.5% |
| 57 | VIRVIR BIOTECHNOLOGY INC | 475,279 | $4.8M | 0.5% |
| 58 | ERASERASCA INC | 258,684 | $4.7M | 0.5% |
| 59 | SISHOULDER INNOVATIONS INC | 226,212 | $4.6M | 0.5% |
| 60 | WAYWAYSTAR HLDG CORP | 203,986 | $4.2M | 0.4% |
| 61 | ATECALPHATEC HLDGS INC | 449,943 | $3.9M | 0.4% |
| 62 | ANNXANNEXON INC | 641,029 | $3.7M | 0.4% |
| 63 | CSTLCASTLE BIOSCIENCES INC | 144,791 | $3.5M | 0.4% |
| 64 | MMEDMINIMED GROUP INC | 226,446 | $3.4M | 0.3% |
| 65 | EIKNEIKON THERAPEUTICS INC | 256,053 | $3.3M | 0.3% |
| 66 | VTRSVIATRIS INC | 200,000 | $3.2M | 0.3% |
| 67 | GRAIL INCPUT | 46,000 | $3.1M | 0.3% |
| 68 | AORTARTIVION INC | 138,940 | $3.1M | 0.3% |
| 69 | AXSMAXSOME THERAPEUTICS INC. | 10,000 | $2.4M | 0.3% |
| 70 | OPRXOPTIMIZERX CORP | 350,347 | $2.0M | 0.2% |
| 71 | NSPRINSPIREMD INC | 2.4M | $1.7M | 0.2% |
| 72 | COAGHEMAB THERAPEUTICS HLDGS INC | 45,000 | $1.7M | 0.2% |
| 73 | LUNGPULMONX CORP | 646,564 | $840,533 | 0.1% |
| 74 | SPRYARS PHARMACEUTICALS INC | 102,700 | $822,627 | 0.1% |
| 75 | FOCLEDAP TMS S A | 154,832 | $802,030 | 0.1% |
| 76 | OVIDOVID THERAPEUTICS INC | 197,947 | $532,477 | 0.1% |
| 77 | ENTERA BIO LTD | 274,497 | $485,860 | 0% |
Source: SEC Form 13F-HR, reporting period 2026-06-30. Values are the manager's filed June-30-style quarter-end marks, not live prices. Research, not investment advice.